- Pharmaceutical Technology-01-02-2013
- Volume 37
- Issue 1
Pharma Conversation & Community
A round up of news from across the web, including trends from social social media platforms.
HITTING THE HEADLINES
FDA Issues Draft Guidance on Electronic Submissions
FDA has issued a draft guidance, Guidance for Industry: Providing Submissions in Electronic Format—Summary Level Clinical Site Data for CDER's Inspection Planning, which is one in a series of documents intended to assist sponsors and applicants making certain regulatory submissions to FDA in electronic format.
US Supreme Court to Hear Pay-for-Delay Case
The US Supreme Court agreed to hear a case that will decide whether brand-name drug companies may pay generic drug-companies to delay introduction of lower-cost generic drugs. The Supreme Court is to review a federal appeals court ruling that upheld a "pay-for-delay" arrangement.
Ranbaxy Recalls Atorvastatin Due to Quality Issues
Ranbaxy Pharmaceuticals is recalling certain lots of its atorvastatin tablets because of possible contamination with small glass particles (less than 1 mm in size). Ranbaxy has ceased atorvastatin manufacturing until it has thoroughly investigated the problem.
INDUSTRY M&As
- Valeant Pharmaceuticals International has completed its acquisition of Medicis Pharmaceutical.
- Isochem has expanded its range of intermediates by acquiring the British fine-chemicals company, Wychem.
- French contract manufacturing firm Synerlab has acquired lyophilization specialist company Lyofal.
- Amgen has agreed to buy Icelandic-based Decode Genetics for $415 million in an all-cash transaction.
SEEKING INPUT
PharmTech is seeking reader input for a future feature on parenteral drug manufacturing. Send your questions and thoughts to the Community Manager, Stephanie Sutton, at
READERS THINK THAT...
Take part in our latest poll at: PharmTech.com/Polls
ON THE BLOG
"Real-time devices for continuous feeding processes were discussed at a seminar I recently attended."
Jennifer Markarian,
See more posts at
MOST TWEETED
- Pharma companies using new analytical methods to ensure quality of medicine ht.ly/g0oIm
- How to optimize continuous processing and make it work in pharmaceutical manufacturing is a crucial issue. ht.ly/g4AtD
Articles in this issue
almost 13 years ago
Pharmaceutical Technology, January 2013 Issue (PDF)almost 13 years ago
Standards-Setting Activities on Impuritiesalmost 13 years ago
A Look Ahead at Manufacturing and Regulationalmost 13 years ago
The Transformation to Process-Centered Organizationalmost 13 years ago
The Latest in IT/Automation/Process controlalmost 13 years ago
A Look Ahead for 2013almost 13 years ago
Strategies in API Scale Upalmost 13 years ago
Report from Brazil January 2013almost 13 years ago
X-ray Powder Diffraction Pattern Indexing for Pharmaceutical Applicationsalmost 13 years ago
Offshoring BiomanufacturingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
